Ordering Recommendation

Use to rapidly detect a panel of common viruses, bacteria, and parasites associated with acute febrile illness or recent acute febrile illness and known exposure to the target pathogens.

Evaluation for more common causes of acute febrile illness (e.g., infections of the upper and lower respiratory tract or gastroenteritis, as well as noninfectious causes) should be considered prior to evaluation with this panel. Results are meant to be used in conjunction with other clinical, epidemiologic, and laboratory data, in accordance with the guidelines provided by the relevant public health authorities.

This test is not intended for screening asymptomatic individuals.

New York DOH Approval Status

This test is New York state approved.

Specimen Required

Patient Preparation

N/A

Collect

Minimum 0.5 ml human whole blood collected in EDTA tubes

Specimen Preparation

Collect blood in EDTA blood tube

Storage/Transport Temperature

Refrigerated

Unacceptable Conditions

Frozen

Remarks

The panel detects and identifies selected bacterial, viral, and parasitic nucleic acids directly from EDTA whole blood collected from individuals with signs and/or symptoms of acute febrile illness or recent acute febrile illness and known or suspected exposure to the following target pathogens: chikungunya virus, dengue virus (serotypes 1, 2, 3 and 4), Leptospira spp., and Plasmodium spp. (including species differentiation of Plasmodium falciparum and Plasmodium vivax / ovale ).

Stability

Ambient: 24 hours
Refrigerated: Up to 7 days

Methodology

Qualitative Polymerase Chain Reaction (PCR)

Performed

Sun-Sat

Reported

1-3 days
All Plasmodium spp. "Detected" results from patients potentially exposed in Southeast Asia should be further investigated for possible P. knowlesi infection, which may require intensive immediate monitoring and treatment.

Reference Interval

Interpretive Data



Compliance Category

FDA

Note

This panel is not intended to be used as the sole basis for diagnosis, treatment, or other management decisions. Positive results do not rule out coinfection with other organisms not included on the panel, nor do negative results rule out infection. Negative results from the panel may require additional testing if clinically indicated. Not all pathogens that cause acute febrile illness are detected by this test, and negative results do not rule out the presence of other infections.
Patient travel history, exposure risk, and consultation of the CDC Yellow Book should be considered prior to use of this panel as some pathogens are more common in certain geographical locations.
A Plasmodium spp. "Detected" result does not provide parasitemia level information. The potential for severe malaria should be considered.
A dengue virus "Detected" result does not provide information on the severity of the disease. The potential for hemorrhagic dengue fever should be considered.
Performance of the test has not been established for monitoring treatment of malaria, dengue fever, chikungunya fever, or leptospirosis.

Hotline History

N/A

CPT Codes

0595U

Components

Component Test Code* Component Chart Name LOINC
3020831 Leptospira spp. 101302-8
3020832 Chikungunya virus 101303-6
3020833 Dengue virus 101304-4
3020834 Plasmodium spp. 101305-1
3020835 Plasmodium Falciparum 101306-9
3020836 Plasmodium vivax/ovale 101307-7
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

Tropical Fever Panel by PCR